A new study from the Women and Infants Research Foundation (WIRF) and international partners has created the world’s first controllable model of acute fetal hypoxia – a condition where an unborn baby gets too little oxygen – using artificial placenta technology.
The findings, published in Reproductive Sciences in December 2025, give scientists an unprecedented look at how fetal brains react to oxygen deprivation before birth and point to potential new ways to detect and manage fetal distress earlier.
Fetal hypoxia is a leading contributor to brain injury, impaired development and even stillbirth or newborn death. Yet doctors lack reliable tools to diagnose and treat it in time.
By developing a standardised, adjustable sheep model of hypoxia, researchers can now precisely control oxygen levels and monitor fetal responses in real time – something that wasn’t possible in large animals before.
“This new model lets us watch, with unprecedented precision, how a fetus responds to low oxygen at different stages of pregnancy,” said the study’s lead investigator, Dr Haruo Usuda from WIRF.
“Understanding these patterns is a critical step toward better diagnosis and potentially new treatments for at-risk babies.”
Key discoveries
The study looked at fetuses at two different stages of gestation – approximately mid and late pregnancy – and found important differences in how they respond to hypoxia:
- Different physiological and molecular responses depending on stage of development: Early and mid-stage fetuses showed distinct patterns in vital signs, blood chemistry and metabolic markers as oxygen levels dropped, suggesting that age matters when it comes to vulnerability and adaptation.
- New potential early warning signals: Researchers identified changes in cell-free RNA (cfRNA) and protein markers in the blood that could one day serve as early indicators of fetal distress, before irreversible damage occurs.
- Evidence of brain injury: After controlled hypoxia, histological analysis showed injury in the brain’s white matter – a critical area for future neurological development – in both gestational groups. This underscores the urgent need for better tools to prevent or reduce such injuries.
“We saw that hypoxia doesn’t just affect the body’s oxygen levels – it triggers complex changes at the molecular level that differ depending on how far along the fetus is,” Dr Usuda explained.
“These insights bring us closer to identifying biomarkers that clinicians might one day use to spot trouble earlier and act faster.”
What it means for future care
Currently, clinicians have limited ways to monitor fetal oxygenation and brain health before birth. This new model offers a powerful research platform to:
- Test and refine monitoring technologies that could detect early signs of hypoxia in pregnancies at risk
- Explore interventions to protect the fetal brain when oxygen levels fall
- Guide the development of biomarker-based diagnostics using cfRNA or other signals found in fetal blood
By opening a window on how the developing brain responds to oxygen deprivation in real time, this research could ultimately lead to better outcomes for babies around the world, especially those born prematurely or with complications.
Research collaborators include The University of Western Australia, Tohoku University Hospital, National University of Singapore, Nipro Corporation, and Murdoch University.
